Item 5.07 Submission of Matters to a Vote of Security Holders.
Decibel Therapeutics, Inc. (the "Company") held its 2022 annual meeting of
stockholders on June 17, 2022. The following is a summary of the matters voted
on at that meeting.
(a)
The stockholders of the Company elected one Class I director, Alison Finger,
M.B.A., to serve for a three-year term expiring at the 2025 annual meeting of
stockholders and until her successor has been duly elected and qualified. The
results of the stockholders' vote with respect to the election of the Class I
director were as follows:
Name For Withheld Broker Non-Votes
Alison Finger, M.B.A. 17,996,169 25,861 3,123,761
(b)
The stockholders of the Company ratified the appointment of Ernst & Young LLP as
the Company's independent registered public accounting firm for the fiscal year
ending December 31, 2022. The results of the stockholders' vote with respect to
such ratification were as follows:
For Against Abstain Broker Non-Votes
21,129,235 2,824 13,732 -
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses